{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:33:27Z","timestamp":1760056407194,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ncl.2020.09.013","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T22:13:00Z","timestamp":1604700780000},"page":"51-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Advances and Ongoing Controversies in Patent Foramen Ovale Closure and Cryptogenic Stroke"],"prefix":"10.1016","volume":"39","author":[{"given":"Joaquin B.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando D.","family":"Testai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ncl.2020.09.013_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. definitions for use in a multicenter clinical trial. TOAST. trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ncl.2020.09.013_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: The case for a new clinical construct","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2020.09.013_bib3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","article-title":"Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: A population-based study","volume":"14","author":"Li","year":"2015","journal-title":"Lancet Neurol"},{"issue":"22","key":"10.1016\/j.ncl.2020.09.013_bib4","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMoa071422","article-title":"Patent foramen ovale and cryptogenic stroke in older patients","volume":"357","author":"Handke","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.ncl.2020.09.013_bib5","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","article-title":"Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both","volume":"345","author":"Mas","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ncl.2020.09.013_bib6","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2012.02.021","article-title":"Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism","volume":"5","author":"Agarwal","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ncl.2020.09.013_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0002-8703(95)90212-0","article-title":"Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. french study group on patent foramen ovale and atrial septal aneurysm","volume":"130","author":"Mas","year":"1995","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ncl.2020.09.013_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000342900","article-title":"Stroke and patent foramen ovale in young individuals","volume":"69","author":"Piechowski-Jozwiak","year":"2013","journal-title":"Eur Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2020.09.013_bib9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ncl.2020.09.013_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ncl.2020.09.013_bib11","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ncl.2020.09.013_bib12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ncl.2020.09.013_bib14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ncl.2020.09.013_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ncl.2020.09.013_bib17","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","article-title":"Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial","volume":"71","author":"Lee","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5\u20136","key":"10.1016\/j.ncl.2020.09.013_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000488401","article-title":"Patent foramen ovale and cryptogenic stroke or transient ischemic attack: To close or not to close? A systematic review and meta-analysis","volume":"45","author":"Lattanzi","year":"2018","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.ncl.2020.09.013_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","article-title":"Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: Updated systematic review and meta-analysis","volume":"49","author":"Ntaios","year":"2018","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.ncl.2020.09.013_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023761","article-title":"Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: A systematic review and network meta-analysis incorporating complementary external evidence","volume":"8","author":"Mir","year":"2018","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ncl.2020.09.013_bib21","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jacc.2005.08.038","article-title":"Patent foramen ovale: Current pathology, pathophysiology, and clinical status","volume":"46","author":"Hara","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ncl.2020.09.013_bib22","first-page":"859","article-title":"SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The american academy of neurology affirms the value of this statement as an educational tool for neurologists","volume":"93","author":"Horlick","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.ncl.2020.09.013_bib23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/echo.12583","article-title":"Accuracy of conventional transthoracic echocardiography for the diagnosis of intracardiac right-to-left shunt: A meta-analysis of prospective studies","volume":"31","author":"Mojadidi","year":"2014","journal-title":"Echocardiography"},{"issue":"4","key":"10.1016\/j.ncl.2020.09.013_bib24","first-page":"495","article-title":"Identification and quantification of patent foramen ovale-mediated shunts: Echocardiography and transcranial doppler","volume":"6","author":"Mahmoud","year":"2017","journal-title":"Interv Cardiol Clin"},{"issue":"21","key":"10.1016\/j.ncl.2020.09.013_bib25","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","article-title":"Clinical practice. cryptogenic stroke","volume":"374","author":"Saver","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2020.09.013_bib26","article-title":"European position paper on the management of patients with patent foramen ovale. general approach and left circulation thromboembolism","author":"Pristipino","year":"2018","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ncl.2020.09.013_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","article-title":"An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke","volume":"81","author":"Kent","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2020.09.013_bib28","doi-asserted-by":"crossref","first-page":"NP7","DOI":"10.1177\/1747493015607505","article-title":"The utility of the RoPE score in cryptogenic stroke patients","volume":"11","author":"Prefasi","year":"2016","journal-title":"Int J Stroke"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:20:45Z","timestamp":1760005245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0733861920300803"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.09.013","relation":{},"ISSN":["0733-8619"],"issn-type":[{"type":"print","value":"0733-8619"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances and Ongoing Controversies in Patent Foramen Ovale Closure and Cryptogenic Stroke","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}